IN THIS ISSUE:
Policy

• Month in Review
• BIO’s policy agenda
• A move against IPAB and the Medical Device Tax
• UK turning to Value Based Pricing
• Budget cuts and NIH, FDA funding
• Biggest Advancers and Decliners
• Performance of U.S. IPOs
• February Financings
• Grants and Contracts
• February M&A and Partnering
• Clinical Trials
• Patents Issued
• PDUFA Dates
• New Drug Approvals
• Burrill Indicies